FDA-Inspected Site

Spectrum Pharmaceuticals, Inc.

8 FDA inspections are on record for Spectrum Pharmaceuticals, Inc. in Boston, United States.

Clean· No action indicated

Boston, United States · Last updated August 15, 2026

Overview

  • 8 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2022-03-04.

At a glance

Inspections

8

Form 483s

3

EIRs

1

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
28 Feb 2022 – 4 Mar 2022Human DrugsClean
27 Jan 2020 – 12 Feb 2020Human Drugs483View 483 →
9 Mar 2017 – 15 Mar 2017Human DrugsClean
11 May 2016 – 27 May 2016Human Drugs483View 483 →
23 Mar 2015 – 31 Mar 2015Human Drugs483On file
13 Mar 2014 – 18 Mar 2014Human DrugsClean
2 Feb 2012Not recordedClean
23 Feb 2006Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

12 Feb 2020
21 CFR 312.56(b)

Investigator non-compliance

Cited by Lavender M Huskey, Angela Shepas

27 May 2016
21 CFR 312.56(b)

Investigator non-compliance

Cited by Diane C Van Leeuwen

27 May 2016
21 CFR 312.56(a)

Monitoring investigations

Cited by Diane C Van Leeuwen

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 312.56(b)Cited across public-safe Form 483 observations2x
21 CFR 312.56(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Spectrum Pharmaceuticals, Inc.'s 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat